BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Health Decisions Fortifies Marketing and Business Development Teams to Achieve Projected Growth


5/15/2009 4:13:07 PM

(Durham, NC: April 21, 2009) Health Decisions (www.healthdec.com), a full-service clinical research organization (CRO) specializing in adaptive solutions for high-efficiency clinical development, has bolstered its growth strategy with the expansion of its core marketing and business development teams. The new appointments underline the company’s dedication to cultivating new business and sharing the benefits of agile clinical development—an innovative methodology that can cut trial timelines by 10 to 25 percent over traditional research methods.

“Under the current economic circumstances, it’s more important than ever before that the industry take advantage of the benefits of agile methodology,” said Dr. Michael Rosenberg, president and CEO, Health Decisions. “The expansion of our market-facing teams will help spread the word about our company’s offering, ensuring the future of our company and of the drug development industry at large.”

Rosenberg’s breakout session will encourage drug developers to adopt a comprehensive, technology-enabled approach to adaptive research that focuses equally on design and operational components. A panel of experts spanning major clinical research specialties will discuss concrete examples of how such an approach can boost profitability and alleviate the broader financial pressures on the industry.

Marketing Team

Ryan Hedspeth, Director of Marketing

Hedspeth joined Health Decisions in January to direct the strategic planning and development of all marketing communications programs. Previously head of client services at integrated communications firm FWV Distilled, Hedspeth has 13 years of experience marketing clients such as Blue Cross Blue Shield of North Carolina, Cisco Healthcare, Clinexus Clinical Research, eTrials, GlaxoSmithKline, and Trinity Healthcare. Hedspeth earned a Bachelor of Science degree in mass communication from Middle Tennessee State University.

Katie Hendrick, Marketing Specialist

Hendrick joined the team in October, 2008, contributing three years of marketing strategy, advertising and PR experience in the business-to-business and health science industries. Hendrick is a graduate of the UNC-Chapel Hill School of Journalism and Mass Communication, where she earned bachelor’s degrees in journalism and psychology.

Sean Spollen, E-Marketing Specialist

Joining the company in December, 2008, Spollen has three years of experience developing traditional and interactive marketing and social media programs, and is a graduate of Penn State University, where he earned a Bachelor of Science degree in mechanical engineering.

Business Development Team

Mike Watson, Director of Business Development, East

Watson joined Health Decisions in January and is responsible for identifying and growing strategic client relationships in the Eastern United States. A 20-year decorated veteran of the U.S Navy with 16 years of recruiting experience, Watson previously held the positions of vice president of sales for pre-clinical drug discovery CRO CeeTox, Inc. and director of client and candidate development at Orion Intl. Watson holds a Liberal Arts degree from Excelsior College.

David Cerny, Director of Business Development, West

Cerny joined Health Decisions in August, 2008, with 23 years of business development, licensing, and management experience in the biotech and healthcare industries, where he developed strategic business relationships with Johnson and Johnson, Allergan, Genentech, Eli Lilly, Dow, Novartis, Wyeth, and others. Also a former Navy Officer and previously director of business development at Rho, Inc., Aviva Biosciences, and Epicyte Pharmaceuticals, Cerny holds a bachelor’s in biology from UC Santa Barbara and an MBA in strategic management from the United States International University-San Diego.

Terri Sloan, Contracts and Proposals Manager

Sloan joined the business development team in February, bringing 15 years of clinical research experience in both pharmaceutical and government organizations. Previously senior manager, proposals for INC Research, Sloan holds a Bachelor of Science degree in business administration and accounting from NC A&T State University.

Samantha Salvaggio, Business Development Associate

Samantha Salvaggio joined the team in September, 2008 as business development associate. Salvaggio holds a Bachelor of Science degree in pharmaceutical sciences from The Ohio State University.

For sales and marketing information, please contact Mike Watson, Director of Business Development, by email at mwatson@healthdec.com or by phone at 919 967-1111 x133.

For media information, please contact Katie Hendrick, Marketing Specialist, by email at khendrick@healthdec.com or by phone at 919 967-1111 x116.

About Health Decisions

Health Decisions (www.healthdec.com), a global clinical research organization (CRO), leads the industry in trial efficiency. Through integrated technology and agile clinical development methods that apply adaptive principles to both trial design and operations, Health Decisions provides sponsors unprecedented transparency and control and produces results 10 - 25% faster than traditional approaches.

Health Decisions is headquartered in Durham, NC, with over twenty years of drug development experience in setting new standards of speed and accuracy for pharmaceutical, biotech and medical drug and device companies in Phase I-IV trials across all major therapy areas. For more information, please visit the company’s website at www.healthdec.com.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES